SERIAL HIV SEROPREVALENCE SURVEYS - INTERPRETATION, DESIGN, AND ROLE IN HIV AIDS PREDICTION

被引:0
|
作者
ADES, AE
机构
关键词
HUMAN IMMUNODEFICIENCY VIRUS; SEROPREVALENCE; INCIDENCE; MODELING; SIMULATION; SURVEILLANCE; BACK-CALCULATION; PROGRESSION MARKERS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To examine the potential role of seroprevalence surveys in HIV epidemic analysis and prediction, seroprevalence was modeled in terms of age- and time-specific incidence, while taking account of the differential inclusion of infected and uninfected individuals in serosurveys. Differential inclusion had two components, one reflecting disease progression and the other background demographic factors that could change over time. Seroprevalence and progression marker data generated by simulated epidemics showed that age dependence in HIV incidence is a key factor in data interpretation. Time trends in seroprevalence are difficult to interpret, and incidence cannot be estimated from these data unless the effects of disease progression on inclusion are taken into account. Furthermore, changes in incidence could be hard to distinguish from changes in background differential inclusion, casting doubt on the value of smaller sentinel surveys. Uncertainty about differential inclusion severely limits the value of seroprevalence data in improving the precision of HIV/AIDS prediction. Progression marker data are even harder to interpret, since changes in incidence will have effects on the marker value distribution, the size, direction, and timing of which are highly age-dependent. Independent data on differential inclusion would enhance the value of data from seroprevalence surveys.
引用
收藏
页码:490 / 499
页数:10
相关论文
共 50 条
  • [41] Seroprevalence of Toxoplasma gondii Infection among HIV/AIDS Patients in Eastern China
    Shen, Guoqiang
    Wang, Xiaoming
    Sun, Hui
    Gao, Yaying
    KOREAN JOURNAL OF PARASITOLOGY, 2016, 54 (01): : 93 - 96
  • [42] The Regulatory Role of MRCZ in HIV/AIDS Research
    Phiri-Shana, M. E.
    Chekera, R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A99 - A100
  • [43] Role of nanotechnology in HIV/AIDS vaccine development
    Liu, Ying
    Chen, Chunying
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 103 : 76 - 89
  • [44] Thrombocytopenia and AIDS: Possible direct role of HIV
    Borgia, G
    Reynaud, L
    Cicciarello, S
    Tallarino, A
    Fratellanza, G
    Lambiase, A
    Nasti, G
    Simonelli, C
    Foggia, M
    Tirelli, U
    Piazza, M
    AIDS, 1996, 10 (13) : 1606 - 1608
  • [45] The Role of NGOs in HIV/AIDS Prevention in Nigeria
    Davidso Numeh
    Florence Ejike
    Dialectical Anthropology, 2004, 28 (3-4) : 339 - 352
  • [46] Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients: A meta-analysis
    Liu, Lei
    Liu, Li-Na
    Wang, Peng
    Lv, Tian-Tian
    Fan, Yin-Guang
    Pan, Hai-Feng
    ACTA TROPICA, 2017, 176 : 162 - 167
  • [47] The role of HIV protein Nef in the development of HIV/AIDS-associated lymphomas
    Mowla, Shaheen
    Mdletshe, Nontlantla
    CANCER RESEARCH, 2017, 77 (22)
  • [48] SEROPREVALENCE AND RISK FACTORS OF SYPHILIS AMONG HIV/AIDS PATIENTS IN ISTANBUL, TURKEY
    Aydin, Ozlem Altuntas
    Karaosmanoglu, Hayat Kumbasar
    Sayan, Murat
    Ince, Emine Rahsan
    Nazlican, Ozcan
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2015, 23 (01) : 65 - 68
  • [49] Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS
    Ettenhofer, Mark L.
    Foley, Jessica
    Castellon, Steven A.
    Hinkin, Charles H.
    NEUROLOGY, 2010, 74 (15) : 1217 - 1222
  • [50] Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003
    Hurtado, I.
    Alastrue, I.
    Ferreros, I.
    del Amo, J.
    Santos, C.
    Tasa, T.
    Hernandez-Aguado, I.
    Perez-Hoyos, S.
    SEXUALLY TRANSMITTED INFECTIONS, 2007, 83 (01) : 23 - 28